واکسن کووید-۱۹ آکسفورد–آسترازنکا (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "واکسن کووید-۱۹ آکسفورد–آسترازنکا" in Persian language version.

refsWebsite

Global rank Persian rank

10nih.gov

4^th place

5^th place

9doi.org

2^nd place

8worldcat.org

5^th place

12^th place

6bbc.com

20^th place

3^rd place

4web.archive.org

1^st place

3europa.eu

68^th place

179^th place

2astrazeneca.com

low place

2financialexpress.com

798^th place

4,867^th place

2thedailystar.net

593^rd place

3,013^th place

2nytimes.com

7^th place

24^th place

2fiercepharma.com

low place

2who.int

195^th place

129^th place

1thehindu.com

52^nd place

851^st place

1cnn.com

28^th place

65^th place

1clinicaltrials.gov

5,225^th place

5,710^th place

1clinicaltrialsregister.eu

low place

1nature.com

234^th place

262^nd place

1publishing.service.gov.uk

1,877^th place

2,874^th place

1ox.ac.uk

613^th place

413^th place

1bbc.co.uk

8^th place

7^th place

1iranintl.com

2,247^th place

44^th place

1upi.com

290^th place

425^th place

1uol.com.br

74^th place

1,664^th place

1vox.com

484^th place

1,067^th place

1gavi.org

low place

1egypttoday.com

7,145^th place

2,845^th place

1nikkei.com

211^th place

4,755^th place

1pharmaceutical-technology.com

low place

1france24.com

481^st place

392^nd place

1japantoday.com

3,795^th place

4,757^th place

1marketwatch.com

1,303^rd place

2,045^th place

1cbc.ca

115^th place

326^th place

1canada.ca

1,712^th place

2,923^rd place

1swissinfo.ch

1,485^th place

4,884^th place

1admin.ch

279^th place

511^th place

1bloomberg.com

99^th place

231^st place

1koreatimes.co.kr

536^th place

237^th place

1news24.com

1,309^th place

2,944^th place

1thenationalnews.com

1,682^nd place

1,394^th place

1un.org

97^th place

81^st place

admin.ch

"COVID-19 vaccine: Swiss federal government signs agreement with AstraZeneca". admin.ch. Retrieved 16 October 2020.

astrazeneca.com

"Update on the safety of COVID-19 Vaccine AstraZeneca".{{cite web}}: نگهداری CS1: url-status (link)
So AD, Woo J (December 2020). "Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis". BMJ. 371: m4750. doi:10.1136/bmj.m4750. PMC 7735431. PMID 33323376. cited "Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond" (Press release). AstraZeneca. 4 June 2020.

bbc.co.uk

"Covid-19: Oxford-AstraZeneca coronavirus vaccine approved for use in UK". BBC News. BBC. 30 December 2020. Retrieved 30 December 2020.

bbc.com

«بریتانیا به واکسن کرونای آکسفورد-آسترازنکا مجوز داد». BBC News فارسی. دریافت‌شده در ۲۰۲۰-۱۲-۳۰.
"เรื่องน่ารู้ของวัคซีนโควิด-19 ที่ไทยสั่งซื้อ" [COVID-19: Progress of the Thai Vaccine Purchased from AstraZeneca]. BBC ไทย (به تایلندی). Retrieved 5 January 2021.
"เรื่องน่ารู้ของวัคซีนโควิด-19 ที่ไทยสั่งซื้อ" [COVID-19: Progress of the Thai Vaccine Purchased from AstraZeneca]. BBC ไทย (به تایلندی). Retrieved 5 January 2021.
"เรื่องน่ารู้ของวัคซีนโควิด-19 ที่ไทยสั่งซื้อ" [COVID-19: Progress of the Thai Vaccine Purchased from AstraZeneca]. BBC ไทย (به تایلندی). Retrieved 5 January 2021.
"AstraZeneca to begin making vaccine". BBC News Online. 5 June 2020. Retrieved 1 July 2020.
«آسترازنکا تولید و فروش واکسن کرونا را متوقف می‌کند». بی‌بی‌سی فارسی. ۱۹ اردیبهشت ۱۴۰۳.

bloomberg.com

"Philippines, AstraZeneca Sign Deal for 2.6 Million Doses". Bloomberg. 27 November 2020.

canada.ca

Health Canada (2 October 2020). "Health Canada begins first authorization review of a COVID-19 vaccine submission". gcnws. Retrieved 30 December 2020.

cbc.ca

"With no successful vaccine candidates yet, Canada signs deal to secure 20M more COVID-19 vaccine doses". CBC News. 25 September 2020.

clinicaltrials.gov

"Investigating a Vaccine Against COVID-19". ClinicalTrials.gov (Registry). United States National Library of Medicine. 26 May 2020. NCT04400838. Archived from the original on 11 October 2020. Retrieved 14 July 2020.

clinicaltrialsregister.eu

"A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19". EU Clinical Trials Register (Registry). European Union. 21 April 2020. EudraCT 2020-001228-32. Archived from the original on 5 October 2020. Retrieved 3 August 2020.

cnn.com

edition.cnn.com

Walsh, Nick; Shelley, Jo; Duwe, Eduardo; Bonnett, William (27 July 2020). "The world's hopes for a coronavirus vaccine may run in these health care workers' veins". CNN. São Paulo. Archived from the original on 3 August 2020. Retrieved 3 August 2020.

doi.org

O'Reilly P (26 May 2020). "A Phase III study to investigate a vaccine against COVID-19" (Registry). doi:10.1186/ISRCTN89951424. ISRCTN89951424. {{cite journal}}: Cite journal requires |journal= (help)
Callaway E (23 November 2020). "Why Oxford's positive COVID vaccine results are puzzling scientists". Nature (به انگلیسی). 588 (7836): 16–18. doi:10.1038/d41586-020-03326-w. PMID 33230278.
Voysey, Merryn; Costa Clemens, Sue Ann; Madhi, Shabir A.; Weckx, Lily Y.; Folegatti, Pedro M.; Aley, Parvinder K.; Angus, Brian; Baillie, Vicky L.; Barnabas, Shaun L. (2021-03-06). "Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials". Lancet (London, England). 397 (10277): 881–891. doi:10.1016/S0140-6736(21)00432-3. ISSN 1474-547X. PMC 7894131. PMID 33617777.
Baraniuk, Chris (February 2021). "Covid-19: How the UK vaccine rollout delivered success, so far". BMJ. 372: n421. doi:10.1136/bmj.n421. ISSN 1756-1833. PMID 33602672.
Baraniuk, Chris (February 2021). "Covid-19: How the UK vaccine rollout delivered success, so far". BMJ. 372: n421. doi:10.1136/bmj.n421. ISSN 1756-1833. PMID 33602672.
Baraniuk, Chris (February 2021). "Covid-19: How the UK vaccine rollout delivered success, so far". BMJ. 372: n421. doi:10.1136/bmj.n421. ISSN 1756-1833. PMID 33602672.
So AD, Woo J (December 2020). "Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis". BMJ. 371: m4750. doi:10.1136/bmj.m4750. PMC 7735431. PMID 33323376. cited "Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond" (Press release). AstraZeneca. 4 June 2020.
Baraniuk, Chris (February 2021). "Covid-19: How the UK vaccine rollout delivered success, so far". BMJ. 372: n421. doi:10.1136/bmj.n421. ISSN 1756-1833. PMID 33602672.
Baraniuk, Chris (February 2021). "Covid-19: How the UK vaccine rollout delivered success, so far". BMJ. 372: n421. doi:10.1136/bmj.n421. ISSN 1756-1833. PMID 33602672.

egypttoday.com

"Egypt signs deal to receive Oxford University's COVID-19 vaccine". EgyptToday. 22 June 2020. Retrieved 30 March 2021.

europa.eu

ema.europa.eu

"AstraZeneca's COVID-19 vaccine: benefits and risks in context". European Medicines Agency (EMA) (Press release). 23 April 2021. Retrieved 23 April 2021.
«Vaxzevria (previously COVID-19 Vaccine AstraZeneca)».

ec.europa.eu

"Coronavirus: the Commission signs first contract with AstraZeneca". European Commission. Retrieved 2021-04-11.{{cite web}}: نگهداری CS1: url-status (link)

fiercepharma.com

"AstraZeneca signed up to deliver U.K. shots first. Now it aims to supply COVID-19 vaccine worldwide: report". FiercePharma. Retrieved 30 March 2021.
"AstraZeneca taps Catalent for COVID-19 vaccine finishing, packaging at Italian plant". FiercePharma. Retrieved 16 June 2020.

financialexpress.com

"Covid-19 vaccine: Serum Institute signs up for 100 million doses of vaccines for India, low and middle-income countries". The Financial Express (به انگلیسی). 2020-08-07. Retrieved 2021-01-02.
«Covid-19 vaccine: Serum Institute signs up for 100 million doses of vaccines for India, low and middle-income countries». The Financial Express (به انگلیسی). ۲۰۲۰-۰۸-۰۷. دریافت‌شده در ۲۰۲۱-۰۱-۰۲.

france24.com

"Covid-19: France, Italy, Germany and Netherlands sign vaccine deal for Europe". France 24. 13 June 2020. Retrieved 15 June 2020.

gavi.org

So & Woo (2020), p. 3 cited "New collaboration makes further 100 million doses of COVID-19 vaccine available to low- and middle- income countries" (Press release). Gavi, the Vaccine Alliance. 29 September 2020.^{^{[پیوند مرده]}}

iranintl.com

«اختصاصی ایران اینترنشنال: در صورت تصویب بودجه، واکسن آکسفورد در راه ایران از طریق هند». ایران اینترنشنال. ۲۰۲۱-۰۱-۰۱. دریافت‌شده در ۲۰۲۱-۰۱-۰۲.

japantoday.com

"AstraZeneca agrees to supply Europe with 400 mil doses of COVID-19 vaccine". Japan Today. Retrieved 15 June 2020.

koreatimes.co.kr

"Korea signs agreement with AstraZeneca for COVID vaccine". The Korea Times. 30 November 2020.

marketwatch.com

Calatayud A. "AstraZeneca to supply Europe with Covid-19 vaccine". MarketWatch. Retrieved 15 June 2020.

nature.com

Callaway E (23 November 2020). "Why Oxford's positive COVID vaccine results are puzzling scientists". Nature (به انگلیسی). 588 (7836): 16–18. doi:10.1038/d41586-020-03326-w. PMID 33230278.

news24.com

Felix J (7 January 2021). "SA will get 1 million doses of Covid-19 vaccine from India this month". News24.com. Retrieved 7 January 2021.

nih.gov

pubmed.ncbi.nlm.nih.gov

Callaway E (23 November 2020). "Why Oxford's positive COVID vaccine results are puzzling scientists". Nature (به انگلیسی). 588 (7836): 16–18. doi:10.1038/d41586-020-03326-w. PMID 33230278.
Voysey, Merryn; Costa Clemens, Sue Ann; Madhi, Shabir A.; Weckx, Lily Y.; Folegatti, Pedro M.; Aley, Parvinder K.; Angus, Brian; Baillie, Vicky L.; Barnabas, Shaun L. (2021-03-06). "Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials". Lancet (London, England). 397 (10277): 881–891. doi:10.1016/S0140-6736(21)00432-3. ISSN 1474-547X. PMC 7894131. PMID 33617777.
Baraniuk, Chris (February 2021). "Covid-19: How the UK vaccine rollout delivered success, so far". BMJ. 372: n421. doi:10.1136/bmj.n421. ISSN 1756-1833. PMID 33602672.
Baraniuk, Chris (February 2021). "Covid-19: How the UK vaccine rollout delivered success, so far". BMJ. 372: n421. doi:10.1136/bmj.n421. ISSN 1756-1833. PMID 33602672.
Baraniuk, Chris (February 2021). "Covid-19: How the UK vaccine rollout delivered success, so far". BMJ. 372: n421. doi:10.1136/bmj.n421. ISSN 1756-1833. PMID 33602672.
So AD, Woo J (December 2020). "Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis". BMJ. 371: m4750. doi:10.1136/bmj.m4750. PMC 7735431. PMID 33323376. cited "Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond" (Press release). AstraZeneca. 4 June 2020.
Baraniuk, Chris (February 2021). "Covid-19: How the UK vaccine rollout delivered success, so far". BMJ. 372: n421. doi:10.1136/bmj.n421. ISSN 1756-1833. PMID 33602672.
Baraniuk, Chris (February 2021). "Covid-19: How the UK vaccine rollout delivered success, so far". BMJ. 372: n421. doi:10.1136/bmj.n421. ISSN 1756-1833. PMID 33602672.

ncbi.nlm.nih.gov

Voysey, Merryn; Costa Clemens, Sue Ann; Madhi, Shabir A.; Weckx, Lily Y.; Folegatti, Pedro M.; Aley, Parvinder K.; Angus, Brian; Baillie, Vicky L.; Barnabas, Shaun L. (2021-03-06). "Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials". Lancet (London, England). 397 (10277): 881–891. doi:10.1016/S0140-6736(21)00432-3. ISSN 1474-547X. PMC 7894131. PMID 33617777.
So AD, Woo J (December 2020). "Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis". BMJ. 371: m4750. doi:10.1136/bmj.m4750. PMC 7735431. PMID 33323376. cited "Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond" (Press release). AstraZeneca. 4 June 2020.

nikkei.com

asia.nikkei.com

"AstraZeneca to supply Japan with 120m COVID-19 vaccine doses". Nikkei Asia. Retrieved 30 March 2021.

nytimes.com

Stevis-Gridneff، Matina؛ Sanger-Katz، Margot؛ Weiland، Noah (۲۰۲۰-۱۲-۱۸). «A European Official Reveals a Secret: The U.S. Is Paying More for Coronavirus Vaccines» (به انگلیسی). The New York Times. شاپا 0362-4331. دریافت‌شده در ۲۰۲۱-۰۲-۰۳.
Kirkpatrick, David D. (21 May 2020). "$1.2 Billion From U.S. to Drugmaker to Pursue Coronavirus Vaccine". The New York Times. ISSN 0362-4331. Retrieved 30 March 2021.

ox.ac.uk

"Oxford vaccine reaches one billion doses released | University of Oxford". www.ox.ac.uk (به انگلیسی). Retrieved 2021-07-30.

pharmaceutical-technology.com

"AstraZeneca Covid-19 vaccine deal signed by Australia". www.pharmaceutical-technology.com. Retrieved 30 March 2021.

publishing.service.gov.uk

assets.publishing.service.gov.uk

"Coronavirus Vaccine: Summary of Yellow Card reporting" (PDF). It is known from the clinical trials that the more common side effects for both vaccines can occur at a rate of more than one in 10 doses (for example, local reactions or symptoms resembling transient flu-like symptoms

swissinfo.ch

"Swiss sign next vaccine agreement with AstraZeneca". SWI swissinfo.ch. Retrieved 16 October 2020.

thedailystar.net

"Oxford University-Astrazeneca vaccine: Bangladesh okays it for emergency use". The Daily Star (به انگلیسی). 2021-01-04. Retrieved 2021-02-03.
"Dhaka to have 330 vaccination points". The Daily Star. 18 January 2021. Retrieved 25 January 2021.

thehindu.com

"Already produced 40-50 million dosages of Covishield vaccine, says Serum Institute". The Hindu (به انگلیسی). 28 December 2020.

thenationalnews.com

"Mystery of UK's vaccine contract with AstraZeneca revealed".{{cite news}}: نگهداری CS1: url-status (link)

un.org

news.un.org

"Ghana receives first historic shipment of COVID-19 vaccinations from international COVAX facility". UN News. 24 February 2021. Retrieved 24 February 2021.

uol.com.br

noticias.uol.com.br

«Anvisa aprova uso emergencial das vacinas CoronaVac e AstraZeneca no Brasil». noticias.uol.com.br (به پرتغالی). دریافت‌شده در ۲۰۲۱-۰۲-۰۳.

upi.com

"South Korea approves AstraZeneca COVID-19 vaccine". UPI (به انگلیسی). Retrieved 2021-06-02.

vox.com

Belluz, Julia (2020-11-23). "Why the AstraZeneca-Oxford Covid-19 vaccine is different". Vox (به انگلیسی). Retrieved 2021-02-03.

web.archive.org

Walsh, Nick; Shelley, Jo; Duwe, Eduardo; Bonnett, William (27 July 2020). "The world's hopes for a coronavirus vaccine may run in these health care workers' veins". CNN. São Paulo. Archived from the original on 3 August 2020. Retrieved 3 August 2020.
"Investigating a Vaccine Against COVID-19". ClinicalTrials.gov (Registry). United States National Library of Medicine. 26 May 2020. NCT04400838. Archived from the original on 11 October 2020. Retrieved 14 July 2020.
"A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19". EU Clinical Trials Register (Registry). European Union. 21 April 2020. EudraCT 2020-001228-32. Archived from the original on 5 October 2020. Retrieved 3 August 2020.
«Wayback Machine» (PDF). web.archive.org. ۲۰۲۱-۰۴-۲۳. بایگانی‌شده از اصلی (PDF) در ۲۳ آوریل ۲۰۲۱. دریافت‌شده در ۲۰۲۱-۰۶-۰۲.

who.int

apps.who.int

«Wayback Machine» (PDF). web.archive.org. ۲۰۲۱-۰۴-۲۳. بایگانی‌شده از اصلی (PDF) در ۲۳ آوریل ۲۰۲۱. دریافت‌شده در ۲۰۲۱-۰۶-۰۲.

who.int

"Coronavirus disease (COVID-19): Vaccines". www.who.int (به انگلیسی). Retrieved 2021-04-19.

worldcat.org

Voysey, Merryn; Costa Clemens, Sue Ann; Madhi, Shabir A.; Weckx, Lily Y.; Folegatti, Pedro M.; Aley, Parvinder K.; Angus, Brian; Baillie, Vicky L.; Barnabas, Shaun L. (2021-03-06). "Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials". Lancet (London, England). 397 (10277): 881–891. doi:10.1016/S0140-6736(21)00432-3. ISSN 1474-547X. PMC 7894131. PMID 33617777.
Stevis-Gridneff، Matina؛ Sanger-Katz، Margot؛ Weiland، Noah (۲۰۲۰-۱۲-۱۸). «A European Official Reveals a Secret: The U.S. Is Paying More for Coronavirus Vaccines» (به انگلیسی). The New York Times. شاپا 0362-4331. دریافت‌شده در ۲۰۲۱-۰۲-۰۳.
Baraniuk, Chris (February 2021). "Covid-19: How the UK vaccine rollout delivered success, so far". BMJ. 372: n421. doi:10.1136/bmj.n421. ISSN 1756-1833. PMID 33602672.
Baraniuk, Chris (February 2021). "Covid-19: How the UK vaccine rollout delivered success, so far". BMJ. 372: n421. doi:10.1136/bmj.n421. ISSN 1756-1833. PMID 33602672.
Kirkpatrick, David D. (21 May 2020). "$1.2 Billion From U.S. to Drugmaker to Pursue Coronavirus Vaccine". The New York Times. ISSN 0362-4331. Retrieved 30 March 2021.
Baraniuk, Chris (February 2021). "Covid-19: How the UK vaccine rollout delivered success, so far". BMJ. 372: n421. doi:10.1136/bmj.n421. ISSN 1756-1833. PMID 33602672.
Baraniuk, Chris (February 2021). "Covid-19: How the UK vaccine rollout delivered success, so far". BMJ. 372: n421. doi:10.1136/bmj.n421. ISSN 1756-1833. PMID 33602672.
Baraniuk, Chris (February 2021). "Covid-19: How the UK vaccine rollout delivered success, so far". BMJ. 372: n421. doi:10.1136/bmj.n421. ISSN 1756-1833. PMID 33602672.